CLINICAL_TRIALS
research
· 2017-06-20
Clinical Trial Update: Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins? [Phase 3]
Summary
Phase 3 trial update assessing whether spontaneous bacterial peritonitis still responds to third-generation cephalosporins; current status is not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tanta University | Conditions: Primary Bacterial Peritonitis | Phase 3 | Status: UNKNOWN